• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Table 2Evaluation System for the Prognosis of Metastatic Spine Tumors

CharacteristicScore
General condition (performance status)
Poor (PS 10–40%)0
Moderate (PS 50–70%)1
Good (PS 80–100%)2
Number of extraspinal bone metastases foci
[greater, double equals]30
1 – 21
02
Number of metastases in the vertebral body
[greater, double equals]30
21
12
Metastases to the major internal organs
Unremovable0
Removable1
No metastases2
Primary site of the cancer
Lung, osteosarcoma, stomach, bladder, esophagus, pancreas0
Liver, gall bladder, unidentified1
Others2
Kidney, uterus3
Rectum4
Thyroid, breast, prostate, carcinoid tumor5
Palsy
Complete (Frankel A, B)0
Incomplete (Frankel C, D)1
None (Frankel E)2
Criteria of predicted prognosis:
Total Score (TS) 0–8 < 6 months,
TS 9–11 ≥ 6 months,
TS 12–15 ≥ 1 year

This table has been reproduced from: Tokuhashi, Y., Matsuzaki, H., Oda, H., Oshima, M. & Junnosuke, R. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 2005, 30 (19), 2186–2191 with permission from Lippincott Williams and Wilkins Publishers. Corrections have been made with permission from Yasuaki Tokuhashi MD.

From: Appendix 3, Tokuhashi scoring system: A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis

Cover of Metastatic Spinal Cord Compression
Metastatic Spinal Cord Compression: Diagnosis and Management of Patients at Risk of or with Metastatic Spinal Cord Compression.
NICE Clinical Guidelines, No. 75.
National Collaborating Centre for Cancer (UK).
Copyright © 2008, National Collaborating Centre for Cancer.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licenses issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.